ICRM
CELG

Insight Capital Research & Management’s Celgene Corp CELG Stock Holding History

Insight Capital Research & Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.95M Sell
13,388
-154
-1% -$21K 1.1% 39
2017
Q2 		$1.76M Buy
+13,542
New +$1.66M 1.03% 44
2015
Q2 		– Sell
-32,900
Closed -$3.79M – 149
2015
Q1 		$3.79M Sell
32,900
-277
-0.8% -$33.1K 0.95% 45
2014
Q4 		$3.71M Sell
33,177
-567
-2% -$59.8K 0.95% 41
2014
Q3 		$3.2M Buy
+33,744
New +$3.05M 0.83% 59

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Insight Capital Research & Management's CELG Position: Q3 2017 in Review

Insight Capital Research & Management reduced its Celgene Corp (CELG) stake by 1.1% in Q3 2017, selling an estimated $21K and leaving 13,388 shares worth $1.95M. The position accounts for 1.1% of the portfolio, ranked #39.

Insight Capital Research & Management first reported a position in CELG in Q3 2014 and has held it in 5 quarters since. The position peaked at $3.79M in Q1 2015. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Insight Capital Research & Management held 13,388 shares of Celgene Corp worth $1.95M as of Q3 2017.
  • Insight Capital Research & Management sold 154 Celgene Corp shares in Q3 2017, an estimated $21K.
  • Celgene Corp made up 1.1% of Insight Capital Research & Management's portfolio in Q3 2017, its #39 holding.
  • Insight Capital Research & Management first reported a position in Celgene Corp in Q3 2014 and has held it in 5 quarters since.
  • Insight Capital Research & Management's Celgene Corp position peaked at $3.79M in Q1 2015.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.